MAP2K1 and systemic lupus erythematosus: PD 98059 prevents the MAPK cascade (MKK1) by blocking the MAPK cascade reaction, as determined using MAPK-based kinase assays, instead of directly inhibiting MKK1 activity [50], further predicting relevant drugs for SLE treatment.